Accessibility Menu
Reliv' International logo

Reliv' International(OTC) RELV

Market Cap$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1993)-95%
5 Year-54%
1 Year-29%
1 Month-16%
$1.83
-8.50%
-0.17Today
Reliv' International last closing stock price
MetricPriceDate
Last closeUSD 1.832026-07-23
Reliv' International stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-19.03%USD 2.262026-07-02
1 month-15.67%USD 2.172026-06-18
3 month-11.65%USD 2.072026-03-30
Year to date-18.67%USD 2.252025-12-31
1 year-29.34%USD 2.592025-07-21
3 year-55.9%USD 4.152023-07-07
5 year-53.67%USD 3.952021-07-22
Since inception-94.78%USD 35.041993-03-08

Reliv' International Financials at a Glance

Market Cap

$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$20.64M

Net Income (TTM)

-$1.26M

EPS (TTM)

-$1.16

P/E Ratio

-1.58

Dividend

$0.00

Beta (Volatility)

-0.27 (Low)

Price

$1.83

Volume

600

Open

$1.83

Previous Close

$1.83

Daily Range

$1.83 - $2.00

52-Week Range

$1.70 - $3.50

Estimated Earnings Date

Mar 28, 2025

RELV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Reliv' International

Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers a diverse range of products aimed at various health needs, including joint health, cognitive functions, and immune support.

Products and Services
  • Proprietary nutritional supplements for various health needs
  • Products include multivitamins, omega 3s, and probiotics
  • Brands include Reliv Classic, Innergize!, and LunaRich C
Growth Outlook
  • Revenue of $5.3 million in Q1 2026 shows steady demand
  • Gross profit margin improved to 45.3% in Q1 2026
  • Expansion into international markets supports long-term growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of $20.5 million
  • Current ratio of 3.26 indicates strong liquidity position
  • Cash and cash equivalents of $3.77 million as of Q1 2026
Reliv' International, Inc. operates in the packaged foods industry, focusing on nutritional supplements that cater to a wide array of health concerns. The company has established a strong presence in multiple countries, including the United States, Canada, and several European and Asian markets. With a commitment to quality and innovation, Reliv' International continues to expand its product offerings and market reach. The recent financial performance indicates a positive trend, with a notable revenue increase in the latest quarter. The gross profit margin has also shown improvement, reflecting effective cost management and product demand. The company's liquidity position is robust, as evidenced by a current ratio significantly above 1, suggesting that it can easily cover short-term liabilities. Investors may find the growth potential appealing, particularly as the company continues to explore new markets and enhance its product lines. The focus on health and wellness aligns with current consumer trends, positioning Reliv' International favorably for future growth.
AI Generated • Jul 28, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

44

CEO

Ryan Andrew Montgomery

Website

www.reliv.com

Headquarters

Chesterfield, MO 63005, US

RELV Financials

Key Financial Metrics (TTM)

Gross Margin

44.05%

Operating Margin

-6.75%

Net Income Margin

-6.11%

Return on Equity

-18.98%

Return on Capital

-18.78%

Return on Assets

-11.57%

Earnings Yield

-63.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.75M

Volume

600

Avg. Volume

247.365

Financials (TTM)

Gross Profit

$9.09M

Operating Income

-$1.39M

EBITDA

-$1.01M

Operating Cash Flow

-$1.12M

Capital Expenditure

-$59.70K

Free Cash Flow

-$1.18M

Cash & ST Invst.

$3.77M

Total Debt

$2.36M

Reliv' International Performance Analysis

Reliv' International annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 27,605,752-15.2%
20232023-12-31USD 24,538,965-11.1%
20242024-12-31USD 20,984,789-14.5%
20252025-12-31USD 20,546,956-2.1%
Reliv' International sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-5.7%
Q32025-09-306.6%
Q42025-12-31-0.6%
Q12026-03-311.8%
Reliv' International annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.85352.7%
20232023-12-31USD 2.38N/A
20242024-12-31USD -1.83N/A
20252025-12-31USD -1.43-21.8%
Reliv' International sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-39.5%
Q32025-09-3056.6%
Q42025-12-31-26.1%
Q12026-03-3166.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$5.30M

+1.8%

Gross Profit

$2.40M

+4.3%

Gross Margin

45.32%

N/A

Market Cap

$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$72.64K

N/A

Employees

44

N/A

Net Income

-$112.26K

+72.1%

EBITDA

-$42.21K

+88.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$3.77M

-17.3%

Total Debt

$2.36M

-5.0%

Accounts Receivable

$364.94K

-36.7%

Inventory

$2.33M

+11.8%

Long Term Debt

$2.11M

-4.2%

Short Term Debt

$248.74K

-11.6%

Return on Assets

-11.57%

N/A

Return on Invested Capital

-16.04%

N/A

Free Cash Flow

$152.43K

+162.7%

Operating Cash Flow

$162.35K

+181.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TOFBTofutti Brands Inc.
$0.65+0.00%
PSYCFPsyched Wellness Ltd
$0.00-40.00%
PNGAFThe Precision Peptide Company Inc
$0.35+10.32%
GLUCGlucose Health, Inc.
$0.35+16.67%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About RELV

What is the current price of Reliv' International?

Reliv' International is trading at $1.83 per share.

What is the 52-week range for Reliv' International?

Over the past 52 weeks, Reliv' International has traded between $1.70 and $3.50.

How much debt does Reliv' International have?

As of the most recent reporting period, Reliv' International reported total debt of $2.36M.

How much cash does Reliv' International have on hand?

Reliv' International reported $3.77M in cash and cash equivalents in its most recent financial results.

What is Reliv' International’s dividend yield?

Reliv' International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services